FILE-In this photo illustration of a group of weight loss medications on a white background. (Photo by: Michael Siluk/UCG/Universal Images Group via Getty Images)
\n\nRecent studies were performed to test GLP-1 drugs as a treatment.
\n\nSome research shows that these obesity medications could work against the hormonal disorder known as PMOS — not only by touting weight loss but also bolstering insulin resistance, hormone balance and ovulation.
\n\nThe Associated Press reported these traits are primary to the disease, which used to be known as polycystic ovary syndrome but was renamed to divert the attention away from ovaries and cysts.
\n\nInitial data from the study, published in the journal Fertility and Sterility in June, found that eight of 11 participants completing the trial lost roughly10% of their body weight.
\n\nCiting the study, the AP reported that the median weight loss among them was about 42 pounds; the median drop in testosterone was 52%. Six women had more periods and four of them went to monthly periods.
\n\nDr. Melanie Cree, PMOS clinic director at Children’s Hospital Colorado, who has led three studies testing GLP-1 drugs for PMOS shared with the AP that most women with PMOS have insulin resistance, which means this…
Original source: https://www.livenowfox.com/tag/science
